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Homozygosity disequilibrium (HD) describes a nonrandom pattern of sizable runs of homozygosity (ROH) that
deviated from a random distribution of homozygotes and heterozygotes in the genome. In this study, we
developed a double-weight local polynomial model for estimating homozygosity intensity. This new estimation
method enables considering the local property and genetic information of homozygosity in the human genome
when detecting regions of HD. By using this new method, we estimated whole-genome homozygosity intensities
by analyzing real whole-genome sequencing data of 959 related individuals from 20 large pedigrees provided by
Genetic Analysis Workshop 19 (GAW19). Through the analysis, we derived the distribution of HD in the human
genome and provided evidence for the genetic component of natural variation in HD. Generalized estimating
equation analysis for 855 related individuals was performed to identify regions of HD associated with diastolic
blood pressure (DBP), systolic blood pressure, and hypertension (HTN), with concomitant adjustment for age
and sex. We identified one DBP-associated and 2 HTN-associated regions of HD. We also studied the gene
regulation of HD by analyzing the real whole-genome transcription data of 647 individuals. A set of gene
expressions regulated by the DBP- and HTN-associated regions of HD was identified. Finally, we conducted
simulation studies to evaluate the performance of our homozygosity association test. The results showed
that the association test had a high power and that type 1 error was controlled. The methods have been
integrated into our developed Loss-of-Heterozygosity Analysis Suite software, which can be downloaded at
http://www.stat.sinica.edu.tw/hsinchou/genetics/loh/LOHAS.htm.Background
Homozygosity disequilibrium (HD) is defined as a nonran-
dom pattern of sizable runs of homozygosity (ROH) that
deviated from a random distribution of homozygotes and
heterozygotes in the genome [1]. The 2 types of ROH are:
narrow-sense and broad-sense ROHs. A narrow-sense
ROH indicates a contiguous stretch of homozygotes in an
intact genomic region [2, 3]. A broad-sense ROH entails a
homozygosity-rich region that contains a small proportion
of heterozygotes, which are caused by genotyping errors,
missing genotypes, or mutations [1]. The genetic mecha-
nisms of HD include autozygosity [2], natural selection [4],
and chromosomal aberrations [5]. Genetic contributions of
HD to the susceptibility of Mendelian diseases, complex* Correspondence: hsinchou@stat.sinica.edu.tw
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difference in HD was also reported [7].
We developed statistical methods and software (Loss-
of-Heterozygosity Analysis Suite [LOHAS]) to dissect
the whole-genome patterns of HD through whole-
genome single nucleotide polymorphism (SNP) analysis
[7]. Our method adopted a broad-sense definition of
ROH. The methods were applied to investigate the asso-
ciation between HD and disease susceptibility [1, 7, 8]
and the relationship between HD and the genetic struc-
tures of global populations [7]. Because no studies had
investigated HD by using whole-genome sequencing
(WGS) data, we expanded our methods and software to
analyze the WGS data set provided by Genetic Analysis
Workshop 18 [9]. The method was based on the
assumption that all rare variants (RVs) have an equalle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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a lower minor allele frequency (MAF) carry less homo-
zygosity information [9].
In this study, we analyzed real WGS and whole-genome
transcription (WGT) data and analyzed simulated data
from Genetic Analysis Workshop 19 (GAW19) and our
previous study [9]. This study aimed to (a) develop new
statistical methods and analysis tools for examining HD in
WGS data; (b) characterize patterns of HD in the human
genome by using WGS data; (c) identify regions of HD
associated with diastolic blood pressure (DBP), systolic
blood pressure (SBP), and hypertension (HTN); (d) exam-
ine gene expression regulated by HD; and (e) evaluate the
power and type 1 error of the proposed genome-wide




GAW19 provided a combined imputation WGS data set,
including deep sequencing data for the whole genomes
of 464 individuals and genome-wide SNP genotyping
data for 495 individuals, derived from 20 large independ-
ent pedigrees enrolled in the Type 2 Diabetes Genetic
Exploration by Next-generation sequencing in Ethnic
Samples (T2D-GENES) Project 2 (filename: chrN-
geno.csv.gz). Constituting the 8,348,663 single nucleotide
variants (SNVs) were 2,769,837 SNPs and 5,578,826 RVs
for odd-numbered autosomes. The clinical data (DBP
and SBP), covariates (age and sex), and antihypertensive
medication of 855 individuals were available (filename:
PHEN.csv). Patients were considered hypertensive if they
had ever taken antihypertensive medication or their DBP
exceeded 90 mm Hg or SBP exceeded 140 mm Hg at
the most recent examination. Among patients who
received hypertensive medication, the values of DBP and
SBP were increased by 5 mm Hg and 10 mm Hg,
respectively, to adjust for the effects of the medication
[10]. The WGT data of 647 individuals were generated
from peripheral blood mononuclear cells by using
Illumina Sentrix Human Whole Genome microarrays
(filename: EXPR.csv) [11]. After data preprocessing,
there were 20,634 transcripts. In addition, GAW19
provided 200 simulation data sets of quantitative trait
Q1 from 849 individuals (filename: SIMPHEN.I.csv). Q1
was generated from a normal distribution and was inde-
pendent of genetic variants in this study. Q1 was used to
evaluate the type 1 error of our homozygosity associ-
ation test. To assess statistical power, we reanalyzed 200
additional simulation data sets of Q1-associated regions
of HD generated in our previous study [9]. We selected
3 regions that represented the 10th, 50th and 90th
percentiles of proportions of RVs on chromosome 21.
Let p denote the probability that all genotypes in theregion were replaced by homozygotes. The 3 regions
were created as Q1-associated regions of HD by using
the following logistic regression model:
Logit pð Þ ¼ b0 þ b1⋅Q1;
where b0 ranged from −25 to −10 with an increment of
5, and b1 ranged from 0.3 to 1 with an increment of 0.1.
Statistical methods
We estimated homozygosity intensities on a chromo-
some as follows. First, we constructed sliding windows
on a chromosome by using the nearest neighbor method
with a bandwidth of h(b), which corresponded to the b%
of SNVs on a chromosome that were contained in each
window (in this study, b% = 5 %). Second, for each indi-
vidual and for each window, we estimated homozygosity
intensity by using a double-weight local polynomial
model. Let {xi, i = 1, ⋯, mc} denote the physical position
of the i th SNV, where mc denotes the number of SNVs
on chromosome c. Let {Yi, i = 1, ⋯, mc} denote an indi-
cator of the homozygous status of the i th SNV, taking
value 1 (0) for a homozygous (heterozygous) SNV. The
estimator of homozygosity intensity at the physical pos-
ition of x ie; λ^ xð Þ ¼ α^0
h i
can be derived by minimizing
the locally weighted least squares criterion E as follows:








L xið ÞfY i−½α0 þ α1 xi−xð Þ
þ⋯þ αp xi−xð Þpg2
ð1Þ
In Eq. (1), kernel weight K(u) was designed to consider
a local correlation of SNVs. A higher weight was
assigned to an SNV closer to the physical position of x.
Locus weight L(xi) was designed to reduce the weights
of the common homozygotes of RVs when defining
ROH, because common homozygotes of RVs that had a
lower MAF carried less homozygosity information. In
this study, we considered cubic kernel weight and locus
weight as follows:
K uð Þ ¼ 1− uj j




L xið Þ ¼ 1;MAFi≥0:05MAFi=0:05; 0≤MAFi < 0:05

The estimates of the homozygosity intensity ranged
from 0 to 1. A higher value indicates a higher homozy-
gosity. Heritability of homozygosity intensity in a region
of HD was calculated by using a variance component
linkage analysis in MERLIN.
Generalized estimation equation (GEE) analysis was
used to examine 855 related individuals and their WGS
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ates (age and sex). In the GEE analysis, DBP values, SBP
values, and HTN status were modeled as 3 separate
response variables. Subsequently, within each sliding
window, the association between each response variable
and homozygosity intensity was examined separately,
with concomitant adjustment for age and sex. An iden-
tity link was used in the analysis of SBP and DBP and a
logit link was used in the analysis of HTN. Furthermore,
we identified gene expression regulated by the significant
region(s) of HD. In GEE analysis, each gene expression
was modeled as a response variable and its association
with homozygosity intensity in the DBP-, SBP-, and
HTN-associated regions of HD was examined individu-
ally, with concomitant adjustment for age and sex.
We performed simulation studies to evaluate the type
1 error and power of homozygosity association tests.
The type 1 error was analyzed by examining the associ-
ation between Q1 and homozygosity intensities, with
covariate adjustments for age and sex, by using GEE
analysis. The test power was evaluated by examining the
association between Q1 and homozygosity intensities inFig. 1 The profiling of homozygosity intensity and regions of HD on chrom
pedigree 27 and 1 independent individual are shown. In each subfigure, th
from 0 to 1, and the horizontal axis represents the physical positions (Mb)
represent homozygosity intensity curves, and the regions shaded in pink cthe 3 Q1-associated regions of HD, with covariate adjust-
ments for age and sex, by using GEE analysis. Through-
out the study, the nominal significance level of statistical
tests was 0.05 after adjusting for the false discovery rate
(FDR) for the multiple-testing problem.
Results
Our analyses were performed without knowledge of the
underlying simulation model. We estimated the whole-
genome homozygosity intensities of 959 individuals. For
example, the profiles of homozygosity intensity of 8 indi-
viduals on chromosome 13 are shown (Fig. 1). In sum-
mary, 25.86 % of individuals (248/959) carried at least 1
sizable regions of HD, satisfying homozygosity intensity
of 0.9 or greater and run length of 5 Mb or greater. The
minimum, first quartile, second quartile, third quartile,
and maximum of lengths of regions of HD were
5.01 Mb, 5.61 Mb, 6.34 Mb, 7.02 Mb, and 45.78 Mb,
respectively. We also calculated the total length of
regions of HD carried by an individual and derived the
distribution of the total lengths over all individuals.
The minimum, first quartile, second quartile, thirdosome 13. The homozygosity intensity curves of seven individuals in
e vertical axis represents homozygosity intensity (HI), which ranged
of anchor SNVs of sliding windows on chromosome 13. Blue curves
orrespond to regions of HD
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5.62, 6.42, 7.20, and 108.46 Mb, respectively. We
found that the regions of HD and their lengths varied
among individuals, but we also observed a pattern of
familial aggregation. For example, for the 4 children of
pedigree 27, the region of HD between 61.99 and
70.37 Mb on chromosome 13 overlapped (Fig. 1).
Average heritability of homozygosity intensity in the
region was 86.96 %.
We performed whole-genome homozygosity associ-
ation tests to identify DBP-, SBP-, and HTN-associated
regions of HD. To examine the multiplicative effect of
homozygosity intensity and reduce the influence of out-
liers, SBP and DBP values were transformed through
log transformation and winsorization with a threshold
of 0.01. After FDR correction, several DBP- or HTN-
associated regions of HD were identified through GEE
analysis (Fig. 2). DBP-associated region of HD was
located between 45.01 and 45.53 Mb on chromosome
11 (adjusted p value = 0.0282). HTN-associated regions
of HD were located between 112.60 and 113.43 Mb on
chromosome 11 (adjusted p value = 0.0295) and be-
tween 35.43 and 36.13 Mb on chromosome 15
(adjusted p value = 0.019). No SBP-associated regions of
HD were identified.Fig. 2 Genetic association between 3 phenotypes and homozygosity inten
regions of HD on odd-numbered chromosomes. The results of homozygosity
are shown. The vertical axis represents the p values (−log10 scale) of the hom
represents the physical positions of the anchor SNVs of sliding windows by ch
statistical significance. Expression regulated by 1 DBP-associated and 2 HTN-a
each volcano plot, the vertical axis represents the p values (−log10 scale) of ge
horizontal axis represents the fold change of gene expression. Genes with p v
and are indicated by green trianglesWe performed GEE analysis to identify gene expres-
sion regulated by the DBP- and HTN-associated regions
of HD, with concomitant adjustment for age and sex.
The results revealed that the expression of 427 genes
was regulated by the DBP-associated region on chromo-
some 11 (see Fig. 2), where 32 genes were found to be
associated with cardiovascular diseases according to the
Genetic Association Database (http://geneticassociationdb.-
nih.gov/). Moreover, the expression of 6 and 2 genes was
regulated by the HTN-associated regions on chromosomes
11 and 15, respectively (see Fig. 2).
We evaluated the type 1 error of the homozygosity as-
sociation tests by analyzing 200 simulation data sets of
quantitative trait Q1 provided by GAW19. After FDR
correction, a homozygosity association analysis of the
849 related individuals calculated the mean of the type 1
errors as 0.0018. We also evaluated the test power by
analyzing 3 Q1-associated regions of HD in 200 simula-
tion data sets [9]. The results showed that the power
increased as the probability p increased, where the prob-
ability p increased as b1 increased. The power of the
homozygosity association test was 1.000 in each condi-
tion, except for the following 3 parameter combinations
(b0, b1) = (−25, 0.4), (−20, 0.3), and (−25, 0.3). The power
for the 3 Q1-associated regions of HD that representedsities, and gene expression regulation of DBP- and HTN-associated
association tests for DBP (red line), SBP (blue line), and HTN (green line)
ozygosity association tests after controlling for FDR. The horizontal axis
romosome. The p values greater than the black reference line reflect
ssociated regions of HD is shown in the 3 volcano plots, respectively. In
neralized estimating equation analysis after controlling for FDR and the
alues greater than the green reference line reflect statistical significance
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RVs on chromosome 21 was: 0.920, 0.985, and 0.775 for
(b0, b1) = (−25, 0.4), respectively; 0.630, 0.820, 0.43 for
(b0, b1) = (−20, 0.3), respectively; and 0.075, 0.070, and
0.125 for (b0, b1) = (−25, 0.3), respectively. The power for
(b0, b1) = (−25, 0.3) was very low because the probability
p was lower than 0.03 for every individual.
Discussion
Our previous study examined the genomic patterns of
HD in 270 samples from populations with African,
Asian, and European ancestry in the International Hap-
Map II Project [7]. The results showed that HD changed
significantly among ethnic groups. In the classification
analysis, samples from different populations were classi-
fied according to the HD results. In contrast, the HD
pattern of the African population was least similar to the
Asian and white populations; the African population had
the fewest regions of HD. In this study, we derived the
distribution of HD in the human genome, provided
evidence for the genetic component of natural variation
in HD, identified regions of HD associated with DBP
and HTN, and also identified a set of gene expressions
regulated by the DBP- and HTN-associated regions of
HD. The follow-up analyses will include, but are not
limited to, a copy number analysis and natural selection
analysis that will facilitate verifying the genetic mechan-
ism of HD.
Conclusions
The contributions of this study are summarized as
follows: First, we developed a new method for consider-
ing the local property and genetic information of homo-
zygosity in homozygosity intensity estimation. In this
method, the assumption that RVs have equal importance
when defining ROH is relaxed and, the method has a
higher power than our previous homozygosity associ-
ation test [9]. Moreover, this method does not require
imputing the homozygosity intensity for the common
homozygote of an RV. Therefore, this method is more
effective computationally than the previous estimation
procedure [9]. Second, our homozygosity intensity ana-
lyses of WGS data provide a whole-genome blueprint of
HD and evidence for the genetic component of natural
variation in HD. Third, the regions and genes of HD
associated with DBP and HTN were identified using
genome-wide homozygosity association tests, enriching
the collection of genes associated with susceptibility to
HTN and other blood pressure–related problems. Finally,
the association analysis of WGS and WGT data revealed
previously unreported evidence of gene regulation of
HD. These findings provide a valuable analysis tool and
knowledge for future medical genomics and population
genomics studies.Acknowledgements
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